| Reaction Details |
|---|
 | Report a problem with these data |
| Target | C-C chemokine receptor type 1 |
|---|
| Ligand | BDBM50359013 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_791051 (CHEMBL1925761) |
|---|
| IC50 | >25118.86±n/a nM |
|---|
| Citation |  Wang, GZ; Haile, PA; Daniel, T; Belot, B; Viet, AQ; Goodman, KB; Sha, D; Dowdell, SE; Varga, N; Hong, X; Chakravorty, S; Webb, C; Cornejo, C; Olzinski, A; Bernard, R; Evans, C; Emmons, A; Briand, J; Chung, CW; Quek, R; Lee, D; Gough, PJ; Sehon, CA CCR2 receptor antagonists: optimization of biaryl sulfonamides to increase activity in whole blood. Bioorg Med Chem Lett21:7291-4 (2011) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| C-C chemokine receptor type 1 |
|---|
| Name: | C-C chemokine receptor type 1 |
|---|
| Synonyms: | C-C CKR-1 | C-C chemokine receptor type 1 (CCR1) | CC-CKR-1 | CCR-1 | CCR1 | CCR1_HUMAN | CD_antigen=CD191 | CMKBR1 | CMKR1 | HM145 | LD78 receptor | MIP-1alpha-R | Macrophage inflammatory protein 1-alpha receptor | RANTES-R | SCYAR1 |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 41180.69 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P32246 |
|---|
| Residue: | 355 |
|---|
| Sequence: | METPNTTEDYDTTTEFDYGDATPCQKVNERAFGAQLLPPLYSLVFVIGLVGNILVVLVLV
QYKRLKNMTSIYLLNLAISDLLFLFTLPFWIDYKLKDDWVFGDAMCKILSGFYYTGLYSE
IFFIILLTIDRYLAIVHAVFALRARTVTFGVITSIIIWALAILASMPGLYFSKTQWEFTH
HTCSLHFPHESLREWKLFQALKLNLFGLVLPLLVMIICYTGIIKILLRRPNEKKSKAVRL
IFVIMIIFFLFWTPYNLTILISVFQDFLFTHECEQSRHLDLAVQVTEVIAYTHCCVNPVI
YAFVGERFRKYLRQLFHRRVAVHLVKWLPFLSVDRLERVSSTSPSTGEHELSAGF
|
|
|
|---|
| BDBM50359013 |
|---|
| n/a |
|---|
| Name | BDBM50359013 |
|---|
| Synonyms: | CHEMBL1924014 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C26H25Cl2F3N4O4S |
|---|
| Mol. Mass. | 617.467 |
|---|
| SMILES | FC(F)(F)c1cc(ccc1Cl)S(=O)(=O)Nc1cc(Cl)cnc1Oc1ccc(cc1)C(=O)NCCN1CCCCC1 |
|---|
| Structure | 
|
|---|
Search and Browse
